| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 120.16 | 1.1% | 17.6% |
| Total Income | 121.58 | 1.1% | 16.8% |
| Expenditure | 108.82 | 3.5% | 25.9% |
| PBT | 12.76 | 15.3% | 27.6% |
| Net Profit | 9.37 | 11.7% | 23.5% |
| OPM | 17.23% | 1.90pp | 7.23pp |
| NPM | 7.71% | 1.11pp | 4.06pp |
| EPS | 1.14 | 11.6% | 23.5% |
GPT Healthcare Reports 12% Y-o-Y Revenue Growth in 9MFY26, Maintains Affordable ARPOB
02 Feb 2026 · 2 Feb, 5:13 pm
Summary
GPT Healthcare Limited reported its financial results for the 9-month period ended December 31, 2025 (9M’FY26). The company's revenue grew by 12% Y-o-Y to Rs 351 crore. EBITDA stood at Rs 65 crore with a margin of 18.20%. Profit After Tax (PAT) was reported at Rs 27.6 crore with a margin of 7.71%. The company maintained a competitive and affordable ARPOB at INR 38,797 while recording steady improvement in occupancy rates. GPT Healthcare commissioned CTVS in ILS-Dum Dum and is scaling the Raipur facility efficiently.
Key Highlights
- 1
Revenue for 9M’FY26 stood at Rs 351 crore a growth of 12% y-o-y
- 2
EBITDA for 9M’FY26 stood at Rs 65.1 crore with a margin of 18.20%
- 3
Profit After Tax for 9M’FY26 stood at Rs 27.6 crore with a margin of 7.71%
- 4
The Company maintained a competitive and affordable ARPOB at INR 38,797
- 5
Including the Raipur facility, the overall occupancy stands at 45%
- 6
Commissioned CTVS in ILS-Dum Dum
- 7
The Raipur facility is scaling efficiently
Management Comments
GPT Healthcare Chairman
Dr. Om Tantia
GPT Healthcare delivered another quarter of strong and consistent performance, underpinned by disciplined execution, improving operating metrics, and broad-based growth across both mature hospitals and newer facilities.
Informational and educational content only. Not investment advice.